A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa
Clinical trial NCT06932003 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06932003
- Sponsor
- Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2025-10-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.